Argent Biopharma Limited has released a press release.
MXC to Commence Australian Dementia Trial with Notre Dame
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Harvey Nichols Expands MGC Derma Distribution in the UK
- MXC Awarded GMP Certification & Manufacturing Licence
- Harvey Nichols To Sell MGC Derma and Derma Plus Cosmetics
- Maltese Government Approves Medicinal Cannabis Legislation
- Corporate Update - CEO steps into Managing Director role
Later from Argent Biopharma
- Appendix 4E and Audited 2018 Financial Report
- MXC Signs Major Distribution Agreement for GMP Products
- Contract Default Notice Issued To Varm Cosmo
- Sale of MGC Derma to Strategic Partner Cannaglobal Canada
- CannEpil Authorised to Commence Australian Sales
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma